Abstract
Introduction
With the advancement of imaging like highresolution ultrasonography (USG), computerized tomography (CT) and magnetic resonance imaging (MRI), incidentally discovered adrenal tumors are more frequently reported including pheochromocytoma 1, 2 . Due to the limitation of USG imaging, CT has been used for better technique to diagnose the adrenal masses and it is reported to identify adrenal masses as small as 0.5 cm or small in diameter 3 . The prevalence of adrenal masses is at least 2% on CT scanin comparison to other suspected adrenal pathology 4, 5 . Among patients with adrenal incidentalomas, approximately 5.1% 5 to 6.5% 4 , even up to 23% 2 , proved to have pheochromocytomas. And 10% of adrenal pheochromocytomas present as adrenal incidentalomas, even when clinically silent 5 .
Pheochromocytomas are rare tumors found in less than 1% of the populations with hypertension. Although the majority of patients are symptomatic, 10-30% of pheochromocytomas are clinically silent 6 . Identification of the hormone activity and malignant potential among patients with adrenal incidentalomas are clinically important. Failure to recognize and treat a pheochromocytoma could prove a fatal oversight.
Case Report
A 43-year-old woman, hypertensive but with well controlled blood pressure on drug amlodipin for 10 yrs came to outpatient department(OPD ) of Sarkari Karmochari Hospital , Dhaka with mild discomfort in abdomen and back pain for 2 months . On examination-there was no oedema, no apparent body weight change, not much hair loss or hirsutism, no purple striae on abdomen or limbs were noted, except mild tenderness in abdomen. At OPD blood pressure (BP ÿwas 125/75 mmHg, heart rate (HR ÿwas 80/min and respiratory rate (RR ÿwas 18/min. On routine investigation USG revealed a fairly large echogenic retroperitoneal mass located in the region of right Adrenal gland.The mass is measuring about 5×4cm in size with central cystic changes and internal necrosis at the suprarenal area, displacing and compressing the adjacent right kidney and right adrenal tumor was suspected. Abdominal CT was preformed and identified an right adrenal tumor ( 5×5 cm), large lobulated mixed dense lesion having soft tissue and fluid density with central necrosis, compressing and displacing the right kidney inferomedially and IVC anteriorly.On post contrast scan the lesion shows mild inhomogenous enhancement having large central non enhancing area represent necrosis and left adrenal gland appears normal ( Fig1 and Fig 2) .
On the other hand, a series of biochemical tests and hormone study were performed. delineated surrounding capsule. A few cell showed intranuclear pseudo inclusions consistent with pheochromocytoma of the Adrenal Gland (Fig 3) and a Scaled Score was used (PASS <4), to confirm its benign fashion. 7 bilaterally, and 10 % are inherited as an autosomal dominant pattern, 8 9. Diagnosis of pheochromocytoma is usually done by its clinical symptoms. Hypertension is the most common clinical manifestation of pheochromocytoma and is present in 90-100% of patients. Sustained hypertension is seen in half, paroxysmal hypertension in a third, and normal blood pressure in less than a fifth of patients10. The classical triad consisted of headache, palpitation and diaphoresis. Less common symptoms include tremor, angina, nausea, and mass effect from the tumor. Completely silent pheochromocytomas are reported rarely. [9] [10] [11] In our case, she was hypertensive controlled on single drug (tablet amlodipine) but there was no symptom suggestive of pheochromocytoma except occasional abdominal discomfort for last 3months.Ultrasogram reveal there was a mass in the region of right adrenal gland which was supported by CT scan and histopathology report .Therefore, even when clinically silent, patient with an incidentally discovered adrenal mass, should be carefully screened for the possibility of functional activity of pheochromocytoma, the diagnosis is made with the demonstration of elevated level ofcirculatory urinary catecholamines or metabolites. Typically, a measurement of urinary catecholamines or metabolites that is two or three times above the upper limit of normal is considered diagnostic of pheochromocytoma 11 .Because of the dramatic symptoms; functional tumors are usually small when detected, whereas nonfunctional tumors may be large. 12 For pheochromocytomas, the mean diameter of incidental tumors was also significantly larger than that of symptomatic tumors. 13, 14 The size and appearance of an adrenal mass on CT or MRI may help distinguish between benign and malignant tumors. Furthermore, I 131 metaiodobenzyl guanidine (MIBG ) can be useful in determining the functional character of a tumor and locating occult secondary or metastatic lesion 15 . Crout and Sjoerdsm found that pheochromocytomas 50 gm or larger are often asymptomatic because secreted catecholamines are metabolized within the tumor 13 . In contrast, tumors smaller A focus of capsular invasion was noted while there was no further evidence of malignancy. Besides, for screening of the possibility of multiple endocrine neoplasia (MEN syndrome) type II, serum level of calcium and thyroid sonography were performed which showed normal serum calcium level and no evidence of thyroid nodule or hyperplasia. There was no family history of pheochromocytoma or MEN type II. Two days after operation, she was discharged.
Discussion
Pheochromocytomas are catecholamineproducing tumors of neuroectodermal origin identified by the presence of cells with positive chromaffin stain. The tumor may occur in patients of any age with equal frequency in both sexes. In general, 10% of these tumors are extra-adrenal, 10% are malignant, 5% occur than 50 gm have slow turnover rates and release free catecholamines into the circulation, exhibiting persistent symptoms and signs15. As in our case, her adrenal tumor is large in size, though weight is less than 50gm, and clinically silent. The imaging of adrenal tumors may help us to distinguish the pheochromocytoma from other tumors. In our case, to determine whether the patient with adrenal incidentaloma has subtle evidence of presence of functional tumor such as Conn's disease, Cushing's syndrome, pheochromocytoma or virilizing or feminizing tumors, serum cortisol level with diurnal rhythm were checked. Combining the history, physical finding, and the biochemical study, the possible diagnoses of Conn's syndrome, subclinical Cushing's syndrome or virilizing or feminizing tumors were initially excluded. With the improvement and more frequent use of imaging study, the incidentally discovered pheochromocytoma may not be a rare finding as we previously thought. Although majority of adrenal incidentalomas are nonhypersecretory benign adenomas, a substantial percentage among these incidentalomas are hormonally active tumor and less frequently, adrenocortical carcinomas, in which early diagnosis and treatment is critical15. For prevention of possible lethal outcome, patients with silent pheochromocytoma scheduled for surgery should be closely evaluated and treated according to the hemodynamic parameters and cardiac function.
